GeneDx Holdings (NASDAQ:WGS) released its Q4 earnings on Monday, February 23, 2026 at 06:30 AM.
Here's what's important from the earnings announcement.
Earnings
GeneDx Holdings beat estimated earnings by 16.67%, reporting an EPS of $0.14 versus an estimate of $0.12.
Revenue was up $25.35 million from the same period last year.
Analysis of Past Earnings
The company beat on EPS by $0.12 in the last quarter, resulting in a 4.15% drop share price change the following day.
Here's a look at GeneDx Holdings's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.37 | 0.1 | 0.09 | 0.1 |
| EPS Actual | 0.49 | 0.5 | 0.27 | 0.6 |
| Revenue Estimate | 104.32M | 85.23M | 79.81M | 82.24M |
| Revenue Actual | 116.74M | 102.69M | 87.11M | 95.64M |
To track all earnings releases for GeneDx Holdings visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.

